FDA Inspection 814918 — Stanford Blood Center
The FDA completed an inspection of Stanford Blood Center on Jan 18, 2013 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Palo Alto, CA (United States)